News
Author: admin als-handoff
-
Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline
SEATTLE, Wash and VANCOUVER, British Columbia, May 30, 2019 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the United States Patent and Trademark Office has granted Achieve a patent (No. 10,300,050) on succinate salt of cytisinicline and…
-
Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
SEATTLE, Wash and VANCOUVER, British Columbia, May 15, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on the cytisinicline clinical development program and announced first quarter 2019 financial results. ORCA-1 Trial Status Achieve’s 254-subject Phase…
-
Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, May 7, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its first quarter 2019 financial results on Wednesday, May 15, 2019. Company management will host a conference…
-
Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
Topline data from ORCA-1 trial expected in the Second Quarter of 2019. SEATTLE, Wash. and VANCOUVER, British Columbia, April 24, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the last study visit for the last subject…
-
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, April 3, 2019 – – Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will present at HC Wainwright Global Life Sciences Conference being held at…